MetaCap

Embecta (EMBC) vs SS Innovations International (SSII)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Embecta (EMBC) has outperformed SS Innovations International (SSII) over the past year, losing 58.7% versus a loss of 78.7%. Embecta is the larger company by market cap ($341.1 million vs $254.9 million), about 1.3 times the size, while SS Innovations International is growing revenue faster (+105.7% vs -3.8%). Embecta pays a dividend yielding 7.64%, while SS Innovations International does not currently pay one.

Embecta converts more of its revenue into profit, with a net margin of 8.8% versus -28.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EMBC-58.68%SSII-78.69%
+18%-34%-85%
Nov 21, 20251 yearNov 20, 2026
EMBC-60.88%SSII-66.13%
+217%+56%-106%
Aug 5, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EMBC versus SSII key metrics
MetricEMBCSSII
Share price$6.02$1.27
Market cap$341.09M$254.86M
1-day change-2.75%-0.78%
YTD return-49.33%-77.64%
1-year return-58.68%-78.69%
P/E ratio (TTM)4.10—
Forward P/E3.42—
EPS (TTM)$1.47$-0.07
Dividend yield7.64%0.00%
Annual dividend$0.46$0.00
Revenue (latest FY)$1.08B$42.48M
Revenue growth (YoY)-3.80%+105.74%
Net income (latest FY)$95.40M$-12.13M
Gross margin62.64%46.00%
Operating margin22.41%-19.29%
Net margin8.83%-28.55%
52-week high$14.78$6.79
52-week low$2.77$1.12
Distance from 52-week high-59.27%-81.30%
Analyst consensusnonenone
Avg. price target upside-33.55%+451.18%
Average volume1.01M86.18K
Shares outstanding56.66M200.68M
Employees1,850483
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • EMBC has outperformed SSII by 20.0 percentage points over the past year.
  • Embecta offers a meaningfully higher dividend yield (7.64% vs 0.00%).
  • Embecta is more profitable, keeping 8.8 cents of every revenue dollar as net income versus -28.5 cents for SS Innovations International.
  • SS Innovations International grew revenue faster in its latest fiscal year (+105.74% vs -3.80%).

About Embecta

EMBC stock →

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.

Health Care · Medical/Dental Instruments · 1,850 employees

About SS Innovations International

SSII stock →

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.

Health Care · Medical/Dental Instruments · 483 employees

EMBC vs SSII FAQ

Which is bigger, Embecta or SS Innovations International?

Embecta (EMBC) is larger, with a market capitalization of $341.09M compared with $254.86M for SS Innovations International (SSII).

Which stock has performed better over the past year, EMBC or SSII?

EMBC returned -58.68% over the past 12 months, compared with -78.69% for SSII (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Embecta or SS Innovations International?

Embecta pays a dividend yielding 7.64%, while SS Innovations International does not currently pay a regular dividend.

Are Embecta and SS Innovations International in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons